Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 15 - Issue 7 - July, 2003

Electrophysiology Corner
A Unique Pacemaker Complication of Thrombus Formation in the Right Internal Jugular Vein Due to Unusual Migration of an Atrial Pacemaker Electrode
04/23/2012

Thomas S. Faber, MD, Andreas Grom, MD, Manfred Zehender, MD

Thomas S. Faber, MD, Andreas Grom, MD...
ABSTRACT: Our report describes the late migration of an atrial screw-in lead into the right internal jugular vein causing subsequent subclinical thrombus formation at the tip of the electrode. Previously initiated anticoagulation for atrial...
ABSTRACT: Our report describes the late migration of an atrial screw-in lead into the right internal jugular vein causing subsequent subclinical thrombus formation at the tip of the electrode. Previously initiated anticoagulation for atrial...
ABSTRACT: Our report describes...
04/23/2012
Journal of Invasive Cardiology
Safety and Efficacy of Low-Dose Intravenous Enoxaparin and Glycoprotein IIb/IIIa Inhibitor Therapy During Percutaneous Coronary
08/01/2008
Louis Carnendran, MD, Robert Borkowski, MD, Bashar Markabawi, MD, Mark F. Warner, MD
Louis Carnendran, MD, Robert Borkowsk...
Enoxaparin, a low molecular weight heparin, has demonstrated superior efficacy over unfractionated heparin (UFH) in the medical management of acute coronary syndromes (ACS), e.g., unstable angina and non-ST elevation myocardial infarction.1...
Enoxaparin, a low molecular weight heparin, has demonstrated superior efficacy over unfractionated heparin (UFH) in the medical management of acute coronary syndromes (ACS), e.g., unstable angina and non-ST elevation myocardial infarction.1...
Enoxaparin, a low molecular...
08/01/2008
Journal of Invasive Cardiology

Column

Editorial Message
Editor`s Message (May 2003)
08/01/2008
Richard E. Shaw, PhD, FACC Editor-in-Chief
Richard E. Shaw, PhD, FACC Editor-in-...
Dear Readers, This issue of the Journal of Invasive Cardiology includes original research articles, case reports, brief reviews, and articles from the Journal special sections “Acute Coronary Syndromes”, “Clinical Decision Making”, and the...
Dear Readers, This issue of the Journal of Invasive Cardiology includes original research articles, case reports, brief reviews, and articles from the Journal special sections “Acute Coronary Syndromes”, “Clinical Decision Making”, and the...
Dear Readers, This issue of the...
08/01/2008
Journal of Invasive Cardiology

Insights

Commentary
Identifying the Vulnerable Plaque (IAGS Proceedings - Part II of II)
08/01/2008
MODERATOR: Jim Zidar PANEL MEMBERS: Klemens Barth; Mike Cowley; Jim Zidar
MODERATOR: Jim Zidar PANEL MEMBERS: K...
(IAGS Proceedings - Part II of II) Nick Hopkins: The preliminary reports on intracranial angioplasty and stenting showed very high morbidity and mortality rates associated with the procedure — particularly in symptomatic patients. As Dr....
(IAGS Proceedings - Part II of II) Nick Hopkins: The preliminary reports on intracranial angioplasty and stenting showed very high morbidity and mortality rates associated with the procedure — particularly in symptomatic patients. As Dr....
(IAGS Proceedings - Part II of...
08/01/2008
Journal of Invasive Cardiology

Feature

Case Report
Delayed Development of a Giant Coronary Pseudoaneurysm After Stent Placement for Chronic Total Occlusion
08/01/2008
Koichi Kishi, MD, Yoshikazu Hiasa, MD, Takefumi Takahashi, MD
Koichi Kishi, MD, Yoshikazu Hiasa, M...
Coronary artery aneurysms have been identified in up to 5% of all coronary angiographic studies. Atherosclerotic, congenital, inflammatory, infectious and traumatic (resulting from coronary intervention) are the most common etiologies....
Coronary artery aneurysms have been identified in up to 5% of all coronary angiographic studies. Atherosclerotic, congenital, inflammatory, infectious and traumatic (resulting from coronary intervention) are the most common etiologies....
Coronary artery aneurysms have...
08/01/2008
Journal of Invasive Cardiology
Case Report
A Rare Combination of Left Main Coronary Artery Fistula to Left Superior Vena Cava with Drainage into the Coronary Sinus in a 74
08/01/2008
Amgad N. Makaryus, MD, Richard Stechel, MD, Stephen Green, MD
Amgad N. Makaryus, MD, Richard Stech...
It is thought that most coronary artery fistulae are congenital in origin, resulting from the persistence of intratrabecular sinusoids during embryonic development.1,2 The persistence of these sinusoids results in the communication between...
It is thought that most coronary artery fistulae are congenital in origin, resulting from the persistence of intratrabecular sinusoids during embryonic development.1,2 The persistence of these sinusoids results in the communication between...
It is thought that most coronary...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
The Clinical Effectiveness of the Prostar® XL Suture-Mediated Percutaneous Vascular Closure Device for Achievement of Hemostasis
08/01/2008
Kenya Nasu, MD, *Etsuo Tsuchikane, MD, **Satoru Sumitsuji, MD, on behalf of the PARADISE Investigators
Kenya Nasu, MD, *Etsuo Tsuchikane, M...
Manual compression has been the standard method employed to achieve hemostasis at the arterial puncture site after percutaneous transluminal coronary angioplasty. However, prior studies suggest that major or minor bleeding complications...
Manual compression has been the standard method employed to achieve hemostasis at the arterial puncture site after percutaneous transluminal coronary angioplasty. However, prior studies suggest that major or minor bleeding complications...
Manual compression has been the...
08/01/2008
Journal of Invasive Cardiology
Clinical Images
Management of Iliac Stent Movement Complicating Peripheral Vascular Intervention: A Rescue Technique When Stent Deployment Malfu
08/01/2008
Walter A. Parham, MD, Sanjeev Puri, MD, Saad R. Bitar, MD, Morton J. Kern, MD
Walter A. Parham, MD, Sanjeev Puri, ...
ABSTRACT: Percutaneous transluminal peripheral angioplasty (PTA), with and without stenting, has become an effective, accepted, and safe approach for treating intermittent claudication and critical leg ischemia in selected patients....
ABSTRACT: Percutaneous transluminal peripheral angioplasty (PTA), with and without stenting, has become an effective, accepted, and safe approach for treating intermittent claudication and critical leg ischemia in selected patients....
ABSTRACT: Percutaneous...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
In-Hospital Complications of Peripheral Vascular Interventions Using Unfractionated Heparin as the Primary Anticoagulant
08/01/2008
Nicolas W. Shammas, MS, MD, *Jon H. Lemke, PhD, Eric J. Dippel, MD, *Dawn E. McKinney, MA, Vickie S. Takes, RN, Monica Youngblut, RN, Melodee Harris, RN, Catherine Harb, Matthew J. Kapalis, BSc, *Jane Holden, RN
Nicolas W. Shammas, MS, MD, *Jon H. ...
Unfractionated heparin is the current antithrombotic of choice in peripheral vascular interventions. Heparin has an unpredictable anticoagulation response, is an indirect thrombin inhibitor, does not inhibit bound thrombin and activates...
Unfractionated heparin is the current antithrombotic of choice in peripheral vascular interventions. Heparin has an unpredictable anticoagulation response, is an indirect thrombin inhibitor, does not inhibit bound thrombin and activates...
Unfractionated heparin is the...
08/01/2008
Journal of Invasive Cardiology
Case Report
The Use of the X-Sizer‚Ñ¢ Transluminal Extraction Catheter as an Adjunct to Stenting of Occluded Saphenous Vein Grafts
08/01/2008
Philip C. Strike, MD, Nicholas M. Robinson, MD, Duncan S. Dymond, MD
Philip C. Strike, MD, Nicholas M. Ro...
Within a decade of surgery, half of all aortocoronary saphenous vein grafts (SVGs) are totally occluded or have severe atherosclerotic disease.1 Redo coronary artery bypass surgery (CABG) has higher mortality and morbidity than the first...
Within a decade of surgery, half of all aortocoronary saphenous vein grafts (SVGs) are totally occluded or have severe atherosclerotic disease.1 Redo coronary artery bypass surgery (CABG) has higher mortality and morbidity than the first...
Within a decade of surgery, half...
08/01/2008
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement

News

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest
plaque analysis
HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease
10/18/2024
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance...
10/18/2024
Cath Lab Digest
Hypertension
New Study Links Obesity to Elevated Hypertension Risk Among Young Middle Eastern Women
10/18/2024
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who...
10/18/2024
Cath Lab Digest

Advertisement

Advertisement

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
Original Contribution
Intravascular Ultrasound in the Assessment of Coronary Artery Anomalies in Young Patients: A Tertiary Center Experience
10/23/2024
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young...
10/23/2024
Journal of Invasive Cardiology
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
Original Contribution
Comparison of Two Vascular Closure Device Strategies for Transfemoral Transcatheter Aortic Valve Replacement Using Suture-Based and Collagen-Plug-Based Techniques and Associated Vascular Complications
10/23/2024
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their...
10/23/2024
Journal of Invasive Cardiology
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest

May 2003 Volume 15 Issue 7

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement